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Abstract
Background and aims. The effect of operation volume on the outcomes of pancreatic surgery has been
a subject of research since the 1990s. In several countries around the world this has led to the
centralization of pancreatic surgery. However, controversy persists as to the benefits of centralization
and what the optimal operation volume for pancreatic surgery actually is. This review summarizes the
data on the effect of centralization on mortality, complications, hospital facilities used and costs
regarding pancreatic surgery.
Materials and Methods. A systematic librarian-assisted search was performed in Pubmed covering the
years from August 1999 to August 2019. All studies comparing results of open pancreatic resections
from high and low-volume centres were included. In total 44 published articles were analysed.
Results: Studies used a variety of different criteria for high-volume (HVC) and low-volume centres
(LVC), which hampers the evaluating of the effect of operation volume. However, mortality in HVCs is
consistently reported to be lower than in LVCs. In addition, failure to rescue critically ill patients is
more common in LVCs. Cost-effectiveness has been also been evaluated in the literature. Length of
hospital stay in particular has been reported be shorter in HVCs than in LVCs.
Conclusion. The effect of centralization on the outcomes of pancreatic surgery has been under active
research and the beneficial effect of it is associated especially with better short-term prognosis after
surgery.
Keywords: Pancreatic cancer; survival; pancreatic surgery; centralized hospital services
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Introduction
The prognosis of pancreatic cancer is poor with an overall five-year survival rate of 5%. It is noteworthy
that if the tumour is detected early, the prognosis improves and five-year survival as high as 30% can
be achieved. Surgery coupled with oncologic therapy is the best option for patients in terms of
survival. Pancreatic surgery is, however, high-risk surgery with over 40% postoperative morbidity rates
and 0-15% postoperative mortality rates. In recent years, financial pressure has also reached health
care organizers to search more cost-effective ways to take care of patients. The effect of the
centralization on pancreatic surgery has been a subject of research worldwide since the 1990s. This
review gathers published data on the effects of the centralization of pancreatic surgery on prognosis
and cost-effectiveness.
Material and Methods
A systematic librarian assisted data search in Pubmed database was performed covering the time span
from August 1999 to August 2019. Both Mesh terms and free text terms in pancreatic surgery,
operation volume and centralization were used as search terms. The search yielded 141 articles which
were manually evaluated. Studies comparing mortality, morbidity, complication distribution,
pathologic reporting, long-term survival and/or costs in open pancreatic resections (PRs) (total
pancreatectomy, pancreatoduodenectomy(PD) or distal resection(DP) or the combined results of
these) between different volume groups were included. Studies not available in English were excluded,
likewise those which did not involve pancreatic surgery or did not report results in relation to
operation volume. No specific criterion was used in defining HVC or LVC. A PRISMA flowchart was
drawn. The results of the studies were summarized in five categories: mortality, complications and
failure to rescue, usage of hospital facilities, long-term survival and quality of pathology.
Results
Included studies
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The systematic search yielded 141 studies. The search history is shown in Supplement 1. After
exclusion, 44 studies were included, see flowchart in Figure 1. Eight studies were published on
Scandinavia, 16 on other parts of Europe. In addition, the search found one study from Japan, Taiwan
and Australia and ten 13 from North America. The search found four systematic reviews or meta-
analyses of which four concentrated on the outcomes of surgery and one on methodological
evaluation.
Definition of HVC
Several criteria have been proposed in the literature and no consensus has been reached. In studies
from the Nordic countries (1-4) LVC has been defined as centre performing under 5-10 PDs annually
except in one study (5) which analysed the data with a cutoff of 40 PDs. The definition of an HVC
varied between 20 and 40 PDs per year in these same studies. Data on distal resections is sparse, but
one study analysed their centralization with an HVC cutoff of 10 annual distal resections(6). Other
European studies(7-19) have set the cutoff for an HVC at 15 to 77 PDs per year and for low-volume
centre at under 16 PDs per year. Studies in the United States of America and Canada (20-28) have also
presented a wide range for both HVCs and LVCs, from 3 to 22 PDs per year for LVCs and from 16 to 97
PDs per year for HVCs. A recent Japanese study (29) categorized hospitals with at least 18 PDs per year
as HVCs and a maximum of 11 PDs per year as LVCs. Table 1.
Effect of operation volume on postoperative mortality
The effect of operation volume on mortality has been described is several studies: the data search
found 33 studies reporting either mortality rates or hazard ratios for mortality in relation to hospital
volume. Table 1. The reported a 30-day mortality rate or in-hospital mortality rate was 0-8.1% in HVCs
and 3.5% - 15% in LVCs in the published studies. The 90-day mortality rate varied from 0% to 5.3% in
HVCs and 9.3% to 16.1% in LVCs. Overall, studies report lower mortality rates in HVCs than in LVCs
despite the heterogeneity of the volume criteria, but statistical significance was not reached in all
studies on PRs, see Table 1. The mortality rates after PD (see Figure 2) resemble those for overall
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mortality after PR, probably due to high the proportions of PDs among the data of PRs. A recent meta-
analysis by Hata et al. (30) pooled 13 studies and categorized studies according to different HVC
criteria into three groups: HVC >19 PDs/year, HVC 20-29PDs/year and HVCs ≥30 PDs/year. Analysis of
each group demonstrated a strong inverse association between operation volume and mortality. The
pooled OR in HVC >19 PDs/year group was 1.94 (1.66-2.26), in HVC 20-29 PDs/year 2.34 (1.81-3.03)
and HVCs ≥30 PDs/year 4.05 (1.96-8.34). Van Rijssen et al. (31) studied factors associated with
postoperative mortality after PD among patients with suspicion of malignancy. They categorized
hospitals not according to the operation volume but according to mortality. They found that male sex,
age >75 years, BMI≥30, histopathological diagnosis of periampullary cancer and hospital volume were
independent risk factors for failure to rescue.
A Swedish study by Derogar et al. (32) described the effect of teaching status and hospital volume on
pancreatic surgery results in five operation volume categories. Most of their data comprised PDs
(85%), but other pancreatic surgery was also included. They found only one significant difference: a
decreased HR for 90-day mortality among hospitals performing four to six PRs per year when
compared with a group performing a maximum of three PRs per year.  They found a strong association
between university hospitals and overall mortality favouring university hospitals (p=0.007). However,
the data also included patients from the beginning of 1990, which may have affected the results.
Effect of operation volume on postoperative complications and failure to rescue
High operation volume was associated in several studies with fewer overall complications. Amini et al.
(20) gathered data on PRs from the American NIS-database (Nationwide Inpatient Sample) covering
some 20% of the community and teaching hospitals in USA. They stated that the OR for morbidity was
1.39-1.47 in low or medium volume centres compared with HVCs. Bateni et al. (21) (27,653 patients)
and Mehta et al. (33) (2,453 patients) analysed the postoperative results of PRs and concluded that
there were significantly more overall complications in LVCs than in HVCs. Mehta et al. (33) added that
surgeon volume is also an independent risk factor for 30-day complication rate. A French nationwide
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study by El Amrani et al. (17) covering 12,333 patients reported that there was more septic,
thromboembolic and haemorrhage complications in LVCs than in HVCs after pancreatic surgery. Ansari
et al. (4) found the same in a Swedish study comprising 212 patients undergoing PD that  haemorrhage
complications especially are more common in LVCs than in HVCs and more blood transfusions are
needed in LVCs. PDs were also analysed by Tran et al. (28) in a study of 15,599 patients. These
authours added that cardiological, pulmonary and nephrologic disorders are more likely to occur in
LVCs. Antila et al. (6) researched in a Finnish nationwide study distal resections and found that more
delayed gastric emptying and gradus B/C pancreatic fistulas occur in LVCs than in HVCs.
Series by Ahola et al. (2) (466 PD patients) and Stella et al. (15) (108 PD patients) found no significant
difference in the incidence of complications. However, Ahola et al. (2) demonstrated that fatal
complications occur more often in LVCs than in HVCs. El Amrani et al. (17) agreed, stating that in
addition to the higher incidence of septic and thromboembolic complications, more patients are lost in
LVCs than in HVCs if these complications occur. The failure-to-rescue pattern has also been mentioned
in American studies reporting results from the NIS database (11,081 PR patients) (34) and Medicare
data (3,405 PR patients) (22). Gani et al. (34) reported that in HVCs (over 30 PRs/year) 5.4% of the
cases presented a failure-to-rescue pattern vs. 11.1% in LVCs (under 8 PRs/year). Ghaferi et al. (22)
added that the risk of failure-to-rescue is 3.12-fold in LVCs (max five PRs/year) vs. HVCs (> 27 PRs/
year).
Effect of operation volume on long-term survival among pancreatic cancer patients
While the beneficial effect of centralization on short term prognosis has been shown in several studies,
the role of operation volume on long-term survival among pancreatic cancer patients has been
controversial. The data search resulted in eight studies describing the effect of operation volume on
either median survival or survival rates among pancreatic cancer patients. Lidsky et al. (24)
concentrated on PDs among 7,086 pancreatic cancer patients and Ahola et al. (1) reported survival
after PRs among PDAC patients. Both studies resulted in significant differences in the median survival
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between LVCs and HVCs (16 months in LVCs vs. 20-26 months in HVCs). In addition, Gooiker et al. (9)
added in their analysis of 11,160 PD patients that one and two-year survival is higher among patients
operated on in HVCs than in LVCs (one-year survival 72% vs. 57% and two-year survival 40% vs. 31%).
Risk for one-year mortality was also analysed by Alsfasser et al. (19) in a study covering 9,566 patients
undergoing pancreatic surgery. They stated that OR is 1.73-1.3 in centres performing fewer than 77
PRs per year, but the data also included benign diseases, which challenges the interpretations of the
results. Westgaard et al. (5) showed that five-year survival among PDAC patients undergoing PD may
be higher in HVCs than in LVCs, 26% vs. 13%. However, Waterhouse et al. (35) with data on 270 and
Derogar et al. (32) with data on 3,298 PRs found no association between hospital volume and long-
term survival in their survival analyses. Waterhouse et al. (35) reported that patients operated on by
surgeons performing fewer than four PRs per year had higher mortality rates and lower survival rates
up to 1.5 years after surgery.
Effect of operation volume on pathology reports
The studies published on the quality of pathology demonstrated the beneficial cumulative effect of
high operation volumes on pathological analyses. Four studies reported results on differences in
pathological analyses or reporting. Onete et al. (36) reported that less information on tumour size or
stage was found in the pathology reports in LVCs than in HVCs. This was corroborated by Ahola et al.
(1) and Westgaard et al. (5), who added that tumour margin clearance evaluation was also more
detailed in HVCs than in LVCs. These studies were based on data prior to 2010. A more recent study by
Lidsky et al. (24) covering the years up to 2012 agreed with these authors the lower number of lymph
nodes detected in LVCs than in HVCs. Standardization of pathology reporting has been shown to
improve the quality of the analysis of PRs (37).
Use of hospital facilities
The effect of operation volume on the use of hospital facilities has been described in terms of length of
hospital stay or stay in intensive care and reinterventions. Studies on PD patients (4) and distal
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resections (6) have presented that more re-operations are performed in LVCs than in HVCs. However,
Ahola et al.(2) studying PD patients in a Finnish nationwide study and Stella et al. (15) concentrating on
PRs found no significant difference between volume groups in frequency of reoperations among PD
patients. A large study by Bateni et al. (21) comprising 27,653 patients undergoing PR revealed that re-
admission is more common among patients operated on in LVCs than in HVCs. This was confirmed by
Sutton et al. (26) in a survey of 9,805 PD patients. Length of hospital stay was also analysed in several
studies resulting in the conclusion that hospital stay is shorter in HVCs than in LVCs (4,16,18,21,23-
26,29,34,38). In addition, Ahola et al. (2) reported that hospital stay among Clavien-Dindo grade III
patients was longer in LVCs than in HVCs. However, the Italian study by Stella et al. (15)  found no
significant difference between LVCs and HVCs in terms of hospital stay after a pancreatic resection.
However, the comparison of studies is difficult without in-depth knowledge of the health system in
each country.
Effect of operation volume on costs
The data search found nine retrospective studies and one meta-analysis on costs after pancreatic
surgery. Ke et al. (39) published a systematic review of 19 studies on the effect of operation volume on
costs in cancer surgery. The systematic review concluded that high operation volume leads to lower
health care costs, but the evidence is inconsistent: 6/10 studies reported an inverse relationship
between hospital volumes and costs, 3/10 a parallel relationship and one study no volume-related
relationship. More recently, a retrospective study by Sutton et al. among PD patients (26) reported
that high operation volume leads to significant cost savings among pancreatic cancer patients. The
association was also apparent in several other studies reporting their results either on pancreatic
cancer patients (29,38) (total of 14,691 patients) or all patients (2,28,40) (total of 16,387 patients).
Enomoto et al. (13) added in an analysis of 3,137 patients from the NIS database that the costs for
patients treated by low-volume surgeons at LVCs are higher than those for patients treated by low-
volume surgeons at HVCs. On the other hand, large retrospective series by Gani et al. (34) (11,081 PR
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patients) (34) and Bateni et al. (21) (27,653 PR patients) found no significant association between costs
and operation volume.
Cost-benefit has not been widely reported. Ahola et al. (2) analysed the cost-benefit association
among pancreatic cancer patients by dividing costs by survival. The analysis showed that costs per
survival are lowest among pancreatic cancer patients operated on at HVCs. Table 2.
Systematic reviews and meta-analyses
The search identified four systematic reviews or meta-analyses. Tol et al. (41) screened reviews
published between 1980 and 2012. They analysed data in two categories: adjusted and non-adjusted
data and discovered an inverse association between high operation volume and mortality. In addition,
adjusted survival data also showed longer survival in HVCs. Hata et al. (30) studied articles published
between 2001 and 2014 and analysed the volume effect on mortality, complications and hospital stay
and agreed on a strong inverse association between mortality and hospital volume. Saulle et al. (42),
concentrated on analysing hospital and surgeon volume. They reported that high surgeon volumes in
HVCs result in beneficial outcomes, but that low surgeon volumes in HVCs also result in lower
mortality, fewer complications and shorter hospital stay than in LVCs with low surgeon volumes. Halm
et al. (43) performed a critical appraisal of the analysis of volume effect in 2002 and reported the
problems of apparent variance in the study methods of different studies. The more recent meta-
analysis mentioned above agreed that differences in the study settings limit the interpretations of the
meta-analysis and, as shown in this review, still challenge the comparison of different studies.
Conclusion
The effect of hospital and surgeon volumes on the prognosis after a PR has been a subject of active
research. The definition of HVC or LVC varies between studies, which complicates the comparison of
different studies and no clear uniform criteria can be set. Despite the differences in the cutoffs, the
published data highlights the beneficial effect of high operation volumes on mortality and failure-to–
rescue. This may mirror the effect of cumulative knowledge, not only among surgeons, but among
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assisting specialities such as anaesthesiology, intensive care, interventional radiology and pathology in 
HVCs. It is noteworthy that many high-volume pancreatic surgery centres may also have high volumes 
in other fields of medicine and surgery. This may result in better availability of resources and 
personnel. These mechanisms speak for the centralization of high-risk surgery, such as pancreatic 
surgery.
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Table 1. 
Total number 
of patients
Definition of 
HVC/LVC
In-hospital 
mortality*/ 30-day 
mortality
90-day mortality
HVC LVC HVC LVC
Studies from the Nordic countries
Nordback et al. 2002
(3) (Finland)
350 >10/<5 PDs 4%* 13%*
Westgaard et al. 2009 
(5) (Norway)
506 ≥40/<40 PRs 5.0% 7.5%
Ansari et al. 2014 (4) 
(Sweden)
221 ≥25/<10 PDs 0.0%* 4.0%*
Ahola et al. 2017 (1) 
(Finland)
467 ≥20/<6 PDs 0% 5.5% 2.5% 11%
Ahola et al. 2019 (2) 
(Finland)
466 ≥20/<6 PDs 0.8% 12.9% 1.9% 16.1%
Antila et al. 2019 (6)
(Finland)
194 ≥10/<4 DPs 0% 0%
Other European studies
Balzano et al. 2008 (7) 
(Italy)
1,576 >14/≤ 6 PDs 5.9% 12.4%
Topal et al. 2008 (18) 
(Belgium)
1,794 ≥10/<10 PDs 5.4%* 10.7%*
de Wilde et al. 2012 
(8) (Netherlands)
2,155 >20/<5 PDs 3.3%* 14.7%*
Gooiker et al. 2014 (9)
(Netherlands) 
11,160 ≥20/≤9 PDs 3.1% 5.2% 4.8% 7.4%
Coupland et al. 2016 
(10)
(England)
2,580 ≥30/<15 PRs OR 
0.78*
OR 1*
Balzano et al. 2016  
(12) (Italy)
10,936 33.5/5.5 PRs 5.0%* 8.9%*
Alsfasser et al. 2016 
(19) (Germany)
9,566 ≥77/<12 PRs OR=1* OR=2.08
*
OR=1 OR=1.99
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van der Geest et 
al.(11) 2016 
(Netherlands)
3,420 ≥40/<5 PDs 4.3% 9.7%
Farges et al. 2017 (13) 
(France) 
22,366 >65/≤25 PRs OR 1 OR 1.9
Stella et al. 2017 (15) 
(Italy)
108 ≥50/≤5 PDs 4.0%* 7.0%*
Krautz et al. (2018) 
(14) Germany
60,858 ≥48/<16 PRs 8.1%* 10.4%*
Capretti et al. 2018 
(16) (Italy)
856 ≥82/≤11 PRs 2.4% 4.1%
el Amrani et al. 2018 
(17) (France)
12,333 ≥20/<10 PDs 5.3%* 9.1%
 Studies conducted elsewhere
Ghaferi et al. 2011 
(22) (USA)
37,865 27/≤2 PRs 3.1%* 13.3%*
Sutton et al. 2014 (26) 
(USA) 
3,411 ≥97/≤22 PDs 1.3%* 3.5%*
Swanson et al. 2014 
(27) (USA)
21,482 ≥40/<5 PDs 1.4% 8.5% 4.7% 14.2%
Yoshioka et al. 2014 
(29) (Japan)
10,652 ≥18/≤11 PDs 2.8%* 5%*
Reames et al. 2014
(44) (USA)
30,732 ≥17-41/≤2-5 PRs 3.2-
4.2%
11-14%
Amini et al. 2015 (20) 
(USA)
35,986 2000 – 2003: 
≥29/<7.6  2004 – 
2007: ≥50/<13, 2008 
– 2011:≥99.5/<22
PRs.
OR=2.57
-2.14*
Kagedan et al. 2016 
(23) (Canada)
2,563 ≥40/<20 PDs 1.5% 2.9% 2.7% 5.2%
O’Mahoney et al. (25) 
2016 (USA) 
17,761 ≥61/<10 PDs 2.0% 9.3%
Tran et al. 2016 (28) 15,599 ≥20/<20 PDs 3%* 7.6%*
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(USA)
Mehta et al. 2016 (33) 
(USA)
2,453 ≥11/11 PRs 5.5% 13.9%
Lidsky et al. 2017 (24) 
(USA)
7,086 ≥16/≤3.3 PDs 2.0% 6.3%
Gani et al. 2017, (34), 
(USA)
11,081 ≤8/≥31 PRs 1.9%* 5.2%*
Bateni et al.2018 (21) 
(USA)
27,653 ≥19/<19 PRs 1.2%* 1.7%*
HVC=high volume centre, LVC=low volume centre, OR=odds ratio, PD=pancreatoduodenectomy, DP=distal 
pancreatectomy, PR=pancreatic resection, *in-hospital mortality, non-statistically significant difference in 
italics
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Table 2
Study Design number 
of 
patients
Conclusion
Ke et al. 2012 (UK), (39) meta-analysis further studies are needed to evaluate the 
effect of centralization
Enomoto et al. 2013 (USA), 
(13)
retrospective 
data 2004-2008
3,317 shorter hospital stay in HVCs and lower 
costs
Yoshioka et al. 2013 (Japan), 
(29)
retrospective 
data 2007-2010
10,652 shorter hospital stay in HVCs and lower 
costs
Shi et al. 2014 (Taiwan), (38) retrospective 
data 1998-2009
4,039 shorter hospital stay in HVCs and lower 
costs
Tran et al. 2015 (USA), (28) retrospective 
data 2000-2010
15,599 lower costs in HVCs
Sutton et al. 2015 (USA), 
(26)
retrospective 
data 2009-2011
9,805 lower costs and fewer readmissions in 
HVCs
Williamsson et al. 2016 
(Sweden), (40)
retrospective 
data 2005-2015
322 shorter hospital stay in HVCs and lower 
costs
Gani et al. 2017 (USA), (34) retrospective 
data 2002-2011
11,081 no association between hospital volume 
and costs
Bateni et al. 2018 (USA), 
(21)
retrospective 
data 2013-2017
27,653 no association between hospital volume 
and costs
Ahola et al. 2019 (Finland), 
(2)
retrospective 
data 2012-2014
466 lower costs in HVCs
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